Login to Your Account



Study Highlights New Target for Antidepressant Therapy

By Sharon Kingman
Staff Writer

Tuesday, May 7, 2013
LONDON – The future development of a new class of antidepressants has edged closer, with the discovery of a molecular pathway that is fundamental to the development of depression. In depression, high levels of stress hormones such as glucocorticoids are linked to a reduced rate by which new brain cells develop – a process called neurogenesis.

To continue reading subscribe now to Science News

Learn More about Science News

Already a subscriber? Sign In or Buy now to activate your subscription